Alex Therien

Alex Therien has an extensive background in the field of biochemistry and biology. Currently, serving as the Vice President and Head of Therapeutic Area Biology at Eikon Therapeutics. Prior to this, Alex held various leadership positions at Merck, Ventus Therapeutics, and Inception Sciences. With a Ph.D. in Biochemistry from McGill University and post-doctoral research at the University of Toronto, Alex has also served as an Adjunct Professor at McGill University, specializing in membrane transport.